8 results
Hyponatremia - Differential Diagnosis Algorithm
Hypovolemic - Give volume
Hypervolemic (Edematous) - Look for and treat underlying cause
Potomania - Tea ... ADH Present and Active ... Pulmonary Diseases ... , CNS Disease, Meds ... #Algorithm #diagnosis
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis infections/year ... lymph nodes Risk ... infection (NTM) • Fungal ... Tuberculosis Diagnosis ... Inhibitor: • Risk
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis infections/year ... lymph nodes Risk ... infection (NTM) • Fungal ... Tuberculosis Diagnosis ... Inhibitor: • Risk
Clarkson’s Disease - Capillary leak syndrome
Epidemiology: Roughly 150 published cases, Median age 50 years, No sex
Clarkson’s Disease - Capillary ... of pulmonary edema ... Prevention of at-risk ... month at least 1 year ... leak #syndrome #diagnosis
Invasive Aspergillus (IA) - Diagnosis and Management
Aspergillus is ubiquitous in nature. Most invasive infections are caused
infections are caused ... complex Classic Risk ... presentations: • Pulmonary ... #Management #treatment ... #fungal #infectiousdiseases
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... event, follow ACC algorithm ... determine if stress test ... days before Pulmonary ... stratification #diagnosis
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
exclude other causes ... cardiomyopathy • Pulmonary ... remains unknown • Final ... teratogenic GDMT meds ... management #cardiology #treatment
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
effusion, INC risk ... Malignancy Risk ... Adenocarcinoma Treatment ... Symptomatic: artificial tears ... muscarinic agonists • Active